Pharmacists encouraged to take leading role in managing minor ailments

A recent event explored ways in which community pharmacy in the UK can take a leading role in managing minor ailments and support the growing trend towards self-care.

Led by Dr Andrew Moore, Director of Pain Research at the Nuffield Department of Anaesthetics at the University of Oxford, the one-day ideas exchange brought together a diverse group of pharmacists, pharmacy technicians, pre-registration pharmacists, pharmacy students and pharmacy practice teachers.

It aimed to provide pharmacists with the tools and information they need to make personalised, evidence-based recommendations for managing aches and pains, and created a forum for all participants to actively identify ways to place community pharmacy at the forefront of pain management.

Medical experts and policymakers agree: self-care can improve both the health of people and certain services within the NHS. This means a greater role for pharmacists.

“Around 57 million GP consultations per year are for minor ailments,” said pharmacist Fin McCaul, an Xchangeathon leader.

“That costs the NHS £2 billion and takes up an hour a day for every GP. But with increasing health literacy and access to technology, consumers are becoming more ‘health smart’ and proactive toward self-care.

“Pharmacists and their (pharmacy) staff should become the recognised experts in managing acute pain and contribute to helping patients manage their own pain.”

Despite the need for increased self-care and the potential for pharmacy staff to play a key part in this self-care journey, a survey of pharmacists and related staff in the UK revealed that nearly a third felt they had insufficient knowledge around different mechanisms of action, doses or contraindications for OTC analgesics – which might hinder their ability to recommend such medicines and/or knowledgeably speak to patients about pain management.

And only around half were very confident when it came to recommending OTC analgesics for back, dental, head.

The Pharmacy Xchangeathon was designed to enable participants to not only understand relevant evidence for OTC pain relief but also to identify practical solutions to support evidence-based decision-making and to equip them to implement best practice when recommending first-line OTC relief.

  1. Andrew Moore kicked off the meeting by discussing why it is crucial for pharmacists to have a thorough understanding of pain.

Antony Chuter, Chair of Pain UK, an alliance of charities representing people in pain, shared patient perspectives of visiting their local pharmacy with minor ailments.

He outlined the simple steps that can be taken to ensure patients have confidence in the pharmacist’s ability to offer support, advice and most importantly, the most appropriate treatment.

Expanding on the theme of self-care, leading pharmacists Fin McCaul and Terry Maguire discussed the evolving landscape, focusing on the NHS and online environment.

The discussions suggested adaptations in order for pharmacies to work in partnership with patients to provide them with the knowledge to manage everyday minor ailments themselves thus easing the pressure on GP services.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

Record quarter for UK biotech as £1bn is raised

UK biotech companies raised more than £1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector...

Moderna regains rights to RSV vaccine from Merck

Moderna has regained all rights to the respiratory syncytial virus (RSV) vaccine (mRNA-1172) from Merck, including rights to develop RSV vaccines for adult populations. mRNA-1172,...

Takeda & Arrowhead to co-develop RNAi therapy for AATLD

Takeda and Arrowhead Pharmaceuticals will collaborate to develop ARO-AAT, a Phase 2 investigational RNA interference (RNAi) therapy in development to treat alpha-1 antitrypsin-associated liver...

Related news

CHMP recommends ViiV’s long-acting regimen for HIV

The Committee for Medicinal Products for Human Use (CHMP) has recommended ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) in combination with Rekambys (rilpivirine injection)...

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

Record quarter for UK biotech as £1bn is raised

UK biotech companies raised more than £1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector...